Human Parvovirus B19: Understanding its rising impact on public health
Human parvovirus B19, discovered in the 1970s, has become a significant concern in public health, particularly due to its ability to cause severe complications in ... Read More
PerkinElmer to acquire Oxford Immunotec for $591m to expand tuberculosis testing capabilities
In a significant move within the diagnostics sector, US-based PerkinElmer has announced its agreement to acquire UK-based Oxford Immunotec for $591 million, translating to $22 ... Read More